Literature DB >> 27846394

Restoring p53 Function in Human Melanoma Cells by Inhibiting MDM2 and Cyclin B1/CDK1-Phosphorylated Nuclear iASPP.

Min Lu, Hilde Breyssens, Victoria Salter, Shan Zhong, Ying Hu, Caroline Baer, Indrika Ratnayaka, Alex Sullivan, Nicholas R Brown, Jane Endicott, Stefan Knapp, Benedikt M Kessler, Mark R Middleton, Christian Siebold, E Yvonne Jones, Elena V Sviderskaya, Jonathan Cebon, Thomas John, Otavia L Caballero, Colin R Goding, Xin Lu.   

Abstract

Entities:  

Year:  2016        PMID： 27846394     DOI： 10.1016/j.ccell.2016.09.019

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


× No keyword cloud information.
  11 in total

1.  A previously identified apoptosis inhibitor iASPP confers resistance to chemotherapeutic drugs by suppressing senescence in cancer cells.

Authors:  Huayi Li; Wenxin Zhang; Kunming Zhao; Dong Zhao; Shanliang Zheng; Ying Hu
Journal:  J Biol Chem       Date:  2020-01-31       Impact factor: 5.157

2.  iASPP is essential for HIF-1α stabilization to promote angiogenesis and glycolysis via attenuating VHL-mediated protein degradation.

Authors:  Dong Zhao; Shanliang Zheng; Xingwen Wang; Hao Liu; Kunming Zhao; Li Li; Ying Hu
Journal:  Oncogene       Date:  2022-02-15       Impact factor: 8.756

3.  Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma.

Authors:  Marie R Webster; Mitchell E Fane; Gretchen M Alicea; Subhasree Basu; Andrew V Kossenkov; Gloria E Marino; Stephen M Douglass; Amanpreet Kaur; Brett L Ecker; Keerthana Gnanapradeepan; Abibatou Ndoye; Curtis Kugel; Alexander Valiga; Jessica Palmer; Qin Liu; Xiaowei Xu; Jessicamarie Morris; Xiangfan Yin; Hong Wu; Wei Xu; Cathy Zheng; Giorgos C Karakousis; Ravi K Amaravadi; Tara C Mitchell; Filipe V Almeida; Min Xiao; Vito W Rebecca; Ying-Jie Wang; Lynn M Schuchter; Meenhard Herlyn; Maureen E Murphy; Ashani T Weeraratna
Journal:  Mol Cell       Date:  2019-12-11       Impact factor: 17.970

4.  Porcine circovirus type 2 ORF3 protein induces apoptosis in melanoma cells.

Authors:  Marina Teras; Edda Viisileht; Merlis Pahtma-Hall; Airi Rump; Viiu Paalme; Pille Pata; Illar Pata; Christelle Langevin; Sirje Rüütel Boudinot
Journal:  BMC Cancer       Date:  2018-12-10       Impact factor: 4.430

5.  Vitexin compound 1, a novel extraction from a Chinese herb, suppresses melanoma cell growth through DNA damage by increasing ROS levels.

Authors:  Nian Liu; Kuan Song Wang; Min Qi; Ying Jun Zhou; Guang Yao Zeng; Juan Tao; Jian Da Zhou; Jiang Lin Zhang; Xiang Chen; Cong Peng
Journal:  J Exp Clin Cancer Res       Date:  2018-11-06

6.  Regulating the CCNB1 gene can affect cell proliferation and apoptosis in pituitary adenomas and activate epithelial-to-mesenchymal transition.

Authors:  Bin Li; Hai-Bo Zhu; Gui-Dong Song; Jian-Hua Cheng; Chu-Zhong Li; Ya-Zhuo Zhang; Peng Zhao
Journal:  Oncol Lett       Date:  2019-09-10       Impact factor: 2.967

7.  iASPP-PP1 complex is required for cytokinetic abscission by controlling CEP55 dephosphorylation.

Authors:  Kun Gao; Yuanyuan Zhang; Qing Shi; Jianong Zhang; Liang Zhang; Huiru Sun; Dongyue Jiao; Xiayin Zhao; Hongru Tao; Youheng Wei; Yuqi Wang; Hexige Saiyin; Shi-Min Zhao; Yao Li; Pingzhao Zhang; Chenji Wang
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

8.  LncRNA XIST Promotes Growth of Human Chordoma Cells by Regulating miR-124-3p/iASPP Pathway.

Authors:  Bao Hai; Xiaoyu Pan; Chuanchao Du; Tianli Mao; Fei Jia; Yu Liu; Yunlong Ma; Xiaoguang Liu; Bin Zhu
Journal:  Onco Targets Ther       Date:  2020-05-26       Impact factor: 4.147

Review 9.  WNT Signaling in Melanoma.

Authors:  Anna Gajos-Michniewicz; Malgorzata Czyz
Journal:  Int J Mol Sci       Date:  2020-07-09       Impact factor: 5.923

10.  Identification of key gene modules and hub genes of human mantle cell lymphoma by coexpression network analysis.

Authors:  Dongmei Guo; Hongchun Wang; Li Sun; Shuang Liu; Shujing Du; Wenjing Qiao; Weiyan Wang; Gang Hou; Kaigang Zhang; Chunpu Li; Qingliang Teng
Journal:  PeerJ       Date:  2020-03-20       Impact factor: 2.984
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.